PPYPX | VIHAX | PPYPX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 9 years | - |
Gain YTD | 0.822 | 1.127 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 498M | 8.22B | 6% |
Annual Yield % from dividends | 5.58 | 4.87 | 114% |
Returns for 1 year | -0.40 | 7.29 | -5% |
Returns for 3 years | -8.03 | 2.41 | -333% |
Returns for 5 years | -10.76 | 13.00 | -83% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SEQAX | 16.18 | 0.10 | +0.62% |
NAA World Equity Income A | |||
TRNZX | 19.66 | 0.07 | +0.36% |
T. Rowe Price International Stock Z | |||
MNDIX | 31.42 | 0.08 | +0.26% |
MFS New Discovery I | |||
ICEUX | 37.97 | 0.02 | +0.05% |
NYLI Epoch International Choice Class I | |||
FBDIX | 118.54 | -0.14 | -0.12% |
Franklin Biotechnology Discovery A |